Methods of treatment using single doses of oritavancin

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/14 (2006.01) A61P 17/00 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2736860

Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against a wide range of bacteria. Methods for the treatment, prophylaxis and prevention of bacterial infection and disease in animals, including humans, using a single dose of oritavancin over the course of therapy, are described.

L'invention porte sur des glycopeptides antibiotiques tels que l'oritavancine, qui présentent une activité significative contre un large éventail de bactéries, et sur des méthodes de traitement, de prophylaxie et de prévention d'infections et de maladies bactériennes chez l'animal dont l'homme utilisant une dose unique d'oritavancine pendant la durée de la thérapie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treatment using single doses of oritavancin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treatment using single doses of oritavancin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment using single doses of oritavancin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1916551

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.